Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods

Autor: Ciesla, Allison Avrich1,2 (AUTHOR) ton4@cdc.gov, Wiegand, Ryan E1 (AUTHOR), Smith, Zachary R3 (AUTHOR), Britton, Amadea1 (AUTHOR), Fleming-Dutra, Katherine E1 (AUTHOR), Miller, Joseph4 (AUTHOR), Accorsi, Emma K5,6 (AUTHOR), Verani, Jennifer R5,7 (AUTHOR), Shang, Nong5 (AUTHOR), Derado, Gordana5 (AUTHOR), Pilishvili, Tamara1 (AUTHOR), Link-Gelles, Ruth1,7 (AUTHOR)
Zdroj: Open Forum Infectious Diseases. May2023, Vol. 10 Issue 5, p1-10. 10p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje